LP172589-6
Danazol
Active
Description
Danazol (brand name Danocrine) is a derivative of the synthetic steroid ethisterone, a modified testosterone. It was approved by the US Food and Drug Administration (FDA) in the early 1970s to treat endometriosis but has essentially been replace by GnRH agonists. Danazol has been used for other indications, including management of menorrhagia, fibrocystic breast disease, immune thrombocytopenic purpura, breast pain (mastodynia) and hereditary angioedema. Danazol is also classified as an anabolic steroid, which places it in the category of sports doping agents. It is listed by the world antidoping agency as a banned substance. Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Danazol
- Part Display Name
- Danazol
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2013-01-31
- Construct for LOINC Short Name
- Danazol
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP172589-6 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP172589-6
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Danazol |
| ru-RU | Russian (Russian Federation) | Даназол |
| zh-CN | Chinese (China) | 丹那唑 Synonyms: 达那唑; |
| it-IT | Italian (Italy) | Danazolo |
| tr-TR | Turkish (Turkey) | Danazol |
| nl-NL | Dutch (Netherlands) | danazol |
| el-GR | Greek (Greece) | Δαναζόλη Synonyms: Δαναζόλη |
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://